Intralymphatic Immunotherapy: Update and Unmet Needs
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Allergen-specific immunotherapy (AIT) is the only allergy treatment that confers long-term symptom amelioration for patients suffering from allergy. The most frequently used allergen application route is subcutaneous injection (SCIT), commonly taken as the gold standard, followed by sublingual (SLIT) or oral (OIT) application of allergen preparations. This is an up-to-date review of the clinical evidence for a novel route of allergen application, i.e., directly into lymph nodes – intralymphatic immunotherapy (ILIT). The major advantages of ILIT over the current AIT approaches are its short duration and the low allergen doses administered. The whole treatment consists of merely 3 ultrasound-guided injections into inguinal lymph nodes 1 month apart. While the number of patients included in randomised controlled trials is still limited, the clinical results for ILIT are encouraging, but more clinical trials are needed, as well as more preclinical work for optimising formulations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Senti, G., Prinz Vavricka, B. M., Erdmann, I., Diaz, M. I., Markus, R., McCormack, S. J., Simard, J. J., Wüthrich, B., Crameri, R., Graf, N., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803725105 · Cited by 364
Self-citationIntralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections
Senti, G., Crameri, R., Kuster, D., Johansen, P., Martinez-Gomez, J. M., Graf, N., Steiner, M., Hothorn, L. A., Grönlund, H., Tivig, C., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.02.026 · Cited by 271
Self-citationThe economic impact of allergic rhinitis and current guidelines for treatment
Meltzer, E. O., & Bukstein, D. A. (2011) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2010.10.014 · Cited by 268
TOTALL: high cost of allergic rhinitis—a national Swedish population-based questionnaire study
Cardell, L.-O., Olsson, P., Andersson, M., Welin, K.-O., Svensson, J., Tennvall, G. R., & Hellgren, J. (2016) · npj Primary Care Respiratory Medicine · doi:10.1038/npjpcrm.2015.82 · Cited by 149
Self-citationAdvances in allergen immunotherapy: Aiming for complete tolerance to allergens
Akdis, C. A., & Akdis, M. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa7390 · Cited by 118
Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy?
Witten, M., Malling, H.-J., Blom, L., Poulsen, B. C., & Poulsen, L. K. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.07.033 · Cited by 100
Hylander, T., Larsson, O., Petersson-Westin, U., Eriksson, M., Kumlien Georén, S., Winqvist, O., & Cardell, L.-O. (2016) · Respiratory Research · doi:10.1186/s12931-016-0324-9 · Cited by 92
Self-citationPatterson, A. M., Bonny, A. E., Shiels, W. E., & Erwin, E. A. (2016) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2015.11.010 · Cited by 74
Self-citation
Cited by
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
Self-citationMechanisms of Allergen-Specific Immunotherapy and Allergen Tolerance
Kucuksezer, U. C., Ozdemir, C., Cevhertas, L., Ogulur, I., Akdis, M., & Akdis, C. A. (2020) · Allergology International · doi:10.1016/j.alit.2020.08.002 · Cited by 173
Self-citationLudvigsson, J., Sumnik, Z., Pelikanova, T., Nattero Chavez, L., Lundberg, E., Rica, I., Martínez-Brocca, M. A., Ruiz de Adana, M., Wahlberg, J., Katsarou, A., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0318 · Cited by 58
“This strategy has been successful in allergy immunotherapy (18) and was tested in T1D in a pilot trial with GAD-alum injected into an inguinal lymph node, in combination with oral vitamin D, with encouraging results (19).”
Mechanisms and Biomarkers of Successful Allergen-Specific Immunotherapy
López, J.-F., Bel Imam, M., Satitsuksanoa, P., Lems, S., Yang, M., Hwang, Y.-K., Losol, P., Choi, J.-P., Kim, S.-H., Chang, Y.-S., et al. (2022) · Asia Pacific Allergy · doi:10.5415/apallergy.2022.12.e45 · Cited by 25
Self-citationZheng, W., Xu, Y.-F., Hu, Z.-M., Li, K., Xu, Z.-Q., Sun, J.-L., & Wei, J.-F. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111488 · Cited by 1
Metadata
- Authors
- Senti, G., Freiburghaus, A. U., Larenas-Linnemann, D., Hoffmann, H. J., Patterson, A. M., Klimek, L., Di Bona, D., Pfaar, O., Ahlbeck, L., Akdis, M., Weinfeld, D., Contreras-Verduzco, F. A., Pedroza-Melendez, A., Skaarup, S. H., Lee, S. M., Cardell, L.-O., Schmid, J. M., Westin, U., Dollner, R., & Kündig, T. M.
- Venue
- International Archives of Allergy and Immunology
- Publisher
- S. Karger AG
- Published
- 2018-11-02
- Volume
- 178
- Issue
- 2
- Pages
- 141-149
- ISSN
- 1018-2438 (ISSN-L)
- 1423-0097
- OpenAlex
- W2899358927
- Cited by
- 103
- References
- 8
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intralymphatic Immunotherapy: Update and Unmet Needs. https://app.cochat.ai/papers/10.1159/000493647
- The paper
- Senti, G., Freiburghaus, A. U., Larenas-Linnemann, D., Hoffmann, H. J., Patterson, A. M., Klimek, L., Di Bona, D., Pfaar, O., Ahlbeck, L., Akdis, M., Weinfeld, D., Contreras-Verduzco, F. A., Pedroza-Melendez, A., Skaarup, S. H., Lee, S. M., Cardell, L.-O., Schmid, J. M., Westin, U., Dollner, R., & Kündig, T. M. (2019). Intralymphatic Immunotherapy: Update and Unmet Needs. International Archives of Allergy and Immunology. https://doi.org/10.1159/000493647
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.